TNFRSF4 and neoplasm: Similar to GITR, OX40 exhibits a dual positive effect on the anti-tumor immune response by supporting the survival and expansion of activated T cells and at the same time deactivating the Treg population within tumors, which can further sustain effector T cell function [23].